Add to ORKGAbstract: Introduction: Drug inhalation via a dry-powder inhaler (DPI) is a convenient, time efficient alternative to nebulizers in the treatment of cystic fibrosis (CF). Efficient drug administration via DPIs depends on the device resistance and adequate ( ≥ 45L/min) inspiratory flows and volumes generated by individuals. Dry-powder mannitol is delivered using a RS01 breath-actuated device developed by Plastiape, for Pharmaxis. The study aim was to determine in vivo if CF patients ’ inspiratory flows and volumes are adequate to use the RS01 DPI device
The purpose of this work was to study a new dry powder inhaler (DPI) of tobramycin capable to simpli...
ABSTRACT: This international phase III study of inhaled dry powder mannitol was a randomised, double...
Background: Although understanding of the scientific basis of aerosol therapy with dry powder inhale...
INTRODUCTION: Drug inhalation via a dry-powder inhaler (DPI) is a convenient, time efficient alterna...
Abstract: Introduction: Drug inhalation via a dry-powder inhaler (DPI) is a convenient, time efficie...
2016 - 2017The inhalation therapy consists of a direct administration of drugs for the treatment of ...
Inhalation of antipseudomonal antibiotics is a cornerstone in treating cystic fibrosis patients. It ...
Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their ...
Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their ...
The aim of this study was to investigate the pulmonary administration of antibiotics as dry powder t...
The aim of this study was to investigate the pulmonary administration of antibiotics as dry powder t...
The purpose of this work was to study a new dry powder inhaler (DPI) of tobramycin capable to simpli...
2010 - 2011The aim of the present PhD project was to design inhalable powder-based formulations for ...
In cystic fibrosis inhalation of drugs for the treatment of CF related lung disease has been proven ...
AbstractIn cystic fibrosis inhalation of drugs for the treatment of CF related lung disease has been...
The purpose of this work was to study a new dry powder inhaler (DPI) of tobramycin capable to simpli...
ABSTRACT: This international phase III study of inhaled dry powder mannitol was a randomised, double...
Background: Although understanding of the scientific basis of aerosol therapy with dry powder inhale...
INTRODUCTION: Drug inhalation via a dry-powder inhaler (DPI) is a convenient, time efficient alterna...
Abstract: Introduction: Drug inhalation via a dry-powder inhaler (DPI) is a convenient, time efficie...
2016 - 2017The inhalation therapy consists of a direct administration of drugs for the treatment of ...
Inhalation of antipseudomonal antibiotics is a cornerstone in treating cystic fibrosis patients. It ...
Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their ...
Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their ...
The aim of this study was to investigate the pulmonary administration of antibiotics as dry powder t...
The aim of this study was to investigate the pulmonary administration of antibiotics as dry powder t...
The purpose of this work was to study a new dry powder inhaler (DPI) of tobramycin capable to simpli...
2010 - 2011The aim of the present PhD project was to design inhalable powder-based formulations for ...
In cystic fibrosis inhalation of drugs for the treatment of CF related lung disease has been proven ...
AbstractIn cystic fibrosis inhalation of drugs for the treatment of CF related lung disease has been...
The purpose of this work was to study a new dry powder inhaler (DPI) of tobramycin capable to simpli...
ABSTRACT: This international phase III study of inhaled dry powder mannitol was a randomised, double...
Background: Although understanding of the scientific basis of aerosol therapy with dry powder inhale...